about
ARID2: a new tumor suppressor gene in hepatocellular carcinomaHypervascular nodule in a fibrotic liver overloaded with iron: identification of a premalignant area with preserved liver architecture.Liver tumors in children with metabolic disordersHBV induced HCC: major risk factors from genetic to molecular levelPrevention of hepatocellular carcinoma: Focusing on antioxidant therapyAccelerated CCl4-induced liver fibrosis in Hjv-/- mice, associated with an oxidative burst and precocious profibrogenic gene expressionIron increases HMOX1 and decreases hepatitis C viral expression in HCV-expressing cellsCritical role of toxicologic pathology in a short-term screen for carcinogenicityPrevention of Hepatocellular CarcinomaIntravenous iron therapy: how far have we come?Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cellsNeoplastic transformation of rat liver epithelial cells is enhanced by non-transferrin-bound ironAsian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.Proteomic analysis of iron overload in human hepatoma cells.The role of iron in the pathophysiology and treatment of chronic hepatitis C.Fibrosis-dependent mechanisms of hepatocarcinogenesisGiant pedunculated hepatocellular carcinoma with hemangioma mimicking intestinal obstructionNon-viral causes of hepatocellular carcinoma.In vitro antioxidant, antibacterial, and cytotoxic activity and in vivo effect of Syngonium podophyllum and Eichhornia crassipes leaf extracts on isoniazid induced oxidative stress and hepatic markersOverexpression of iron regulatory protein 1 suppresses growth of tumor xenografts.Association of meat and fat intake with liver disease and hepatocellular carcinoma in the NIH-AARP cohortHepatocellular carcinoma in thalassemia: A critical reviewThe association of family history of liver cancer with hepatocellular carcinoma: a case-control study in the United States.Hepatic iron overload and hepatocellular carcinoma.Geographic patterns of hepatocellular carcinoma mortality with exposure to iron in groundwater in Taiwanese population: an ecological studyIron homeostasis and tumorigenesis: molecular mechanisms and therapeutic opportunitiesDiagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases.Chronic administration of 2-acetylaminofluorene alters the cellular iron metabolism in rat liver.The utility of iron chelators in the management of inflammatory disorders.Increased hepcidin expression in non-small cell lung cancer tissue and serum is associated with clinical stageRisk factors and mechanisms of hepatocarcinogenesis with special emphasis on alcohol and oxidative stress.Haem-dependent dimerization of PGRMC1/Sigma-2 receptor facilitates cancer proliferation and chemoresistanceHepatocellular carcinoma: management of an increasingly common problemFramework analysis for the carcinogenic mode of action of nitrobenzene.Liver carcinogenesis: from naughty chemicals to soothing fat and the surprising role of NRF2.Hepatocellular carcinoma: epidemiology and risk factorsCurcumin reduces the toxic effects of iron loading in rat liver epithelial cells.Vegetable, fruit and antioxidant nutrient consumption and subsequent risk of hepatocellular carcinoma: a prospective cohort study in Japan.Physiology and pathophysiology of iron in hemoglobin-associated diseases.Intravenous iron monotherapy for the treatment of non-iron-deficiency anemia in cancer patients undergoing chemotherapy: a pilot study.
P2860
Q24607045-B0B6759F-6163-4DA2-917D-C829B735B11CQ24803915-204B643C-57D7-4ACA-B919-793193301E7AQ26770292-9B8D089D-2EA1-4B8B-9EB9-E3121AE5ED20Q26825274-FF99B61F-1442-4A0B-8CF8-338316D275A2Q26853520-ADB49E00-7767-4268-8B95-6FA0E4BB0FCDQ27319418-6EE57B88-EECA-4774-A7FA-D6851C48D67FQ27489764-9B2AC8A6-41E5-44D7-81F4-3F9C810ECBE6Q28075960-C2C168F0-5DEA-4AA7-931A-05EE32A65A78Q28079576-09ADDA8A-8B8C-4340-B3AC-E91011DD739CQ28276678-E14A9D80-F69E-4E04-9796-D747118F3DF6Q28397198-8E906134-8B2A-4D8A-9893-1DB896ABBADAQ28570714-4B15BAC2-0752-4950-BB6B-9E13B31D8F08Q30479629-1279BFE9-5749-4B30-82DD-5EEF8A31DF77Q33231557-0D082024-110B-403A-84AF-5B0DC7D7679EQ33586881-20FC61CC-DBE2-45DC-AC8C-416C970D2BC8Q33865082-1B8C51E8-B8CE-4262-B8FE-4F19A14017BFQ34027865-4FC56EA4-8083-4C1A-BC35-2849A9212F7AQ34041381-A919B9C4-C614-4EB8-AFC1-0A9B7BB8F6C2Q34064597-D5383FE0-C888-4087-9D52-C0E2AC1D1F03Q34077573-D8E2EB85-47C2-475E-96B5-ACA63C226AD1Q34110634-48731C59-15E3-423C-BBE7-B56CAF0C41FEQ34391592-39C8531F-3F37-49D5-B2BF-28909EB4F129Q34601654-A3D7A653-6FDB-4BFD-979F-51ADAA461BA4Q34661782-FAC283C3-0976-434D-A794-4B6B8CBCBDAAQ34670565-23A46A30-D85C-4918-A9B6-B228250EE77CQ35034547-A42D57A3-DA02-4E88-BBF4-EC06A3DC6453Q35144263-16D8BA41-B7FD-44B5-AC1D-00E2A1B1C276Q35231099-4092FC57-7E8F-4747-9D2E-7F48F3B5BCC3Q35283429-997C75D8-3E30-44DE-B201-35922CAA1F38Q36439281-9C009D24-9E07-4D0E-BC45-CA8B98EA21ADQ36444952-D138A9D8-58DD-4C8E-AFD5-F5E0F3310092Q36713044-BA0A30E2-399C-4FEC-AB95-CE9F946878B4Q36746503-2B150667-9348-40C6-8389-6CB649050E0FQ36844974-8B422A99-3265-49C1-A565-3C5817BD9989Q36927013-0CEADB6E-B740-4B7D-BE95-AB00B04F46F4Q37031724-89F88374-3F9C-40B1-9193-619F43542A08Q37038480-5C8BE829-E97C-441D-A312-7769EC92DDF0Q37080894-DE20F878-63F1-496A-8CF1-56E1308916A2Q37082896-8F4266C0-E297-4AB6-9CB4-112388061457Q37164472-C98905D2-ADD0-41D2-B03B-005A0EAFA572
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Iron, hemochromatosis, and hepatocellular carcinoma.
@ast
Iron, hemochromatosis, and hepatocellular carcinoma.
@en
Iron, hemochromatosis, and hepatocellular carcinoma.
@nl
type
label
Iron, hemochromatosis, and hepatocellular carcinoma.
@ast
Iron, hemochromatosis, and hepatocellular carcinoma.
@en
Iron, hemochromatosis, and hepatocellular carcinoma.
@nl
prefLabel
Iron, hemochromatosis, and hepatocellular carcinoma.
@ast
Iron, hemochromatosis, and hepatocellular carcinoma.
@en
Iron, hemochromatosis, and hepatocellular carcinoma.
@nl
P1433
P1476
Iron, hemochromatosis, and hepatocellular carcinoma.
@en
P2093
Kris V Kowdley
P304
P356
10.1016/J.GASTRO.2004.09.019
P407
P433
P577
2004-11-01T00:00:00Z